With the recent advances in whole exome sequencing (WES) technologies, there has been considerable interest in its clinical application. This report assesses the evidence for the use of WES for neurological conditions in pediatric populations after standard diagnostic and genetic tests failed to provide a definitive diagnosis. The goal of the report is to assess the clinical utility of WES, including the presumed diagnostic rate and how a diagnosis changes patient management. 

If you have a Hayes login, click here to view the full report on the Knowledge Center.